Houston biotech cos. begin clinical trials for cancer, Covid-19 treatments
October 20, 2021 at 17:46 PM EDT
Both Iterion and Moleculin are moving their drug candidates through the regulatory pipeline.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|